PureTech Health plc American Depositary Shares (PRTC)

FairStock Score: 50/100 — MIXED

Key Financials

Strengths

• Conservative balance sheet with debt-to-equity of just 0.44, providing financial flexibility

Concerns

• Trades significantly above Graham Number ($8) with negative 127% margin of safety—limited downside protection
• Weak Piotroski F-Score of 0/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

PureTech Health plc American Depositary Shares is a micro-cap healthcare company valued at $426 million. Revenue stands at $6 million. From a quality standpoint, PureTech shows weak Piotroski F-Score of 0/9 signaling deteriorating fundamentals and Altman Z-Score of 2.0 in the grey zone. On valuation, the stock is attractively valued at 10.4x earnings, with trades far above its Graham Number ($8) with no margin of safety. Our composite FairStock Score of 50/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer